Patent · US Expired

Cytarabine derivatives, the preparation and use thereof

US5641758A · kind A · utility

8Cited by
3References
12Claims
0Family size

Inventors

Key dates

Filing dateNov 7, 1994
Grant dateJun 24, 1997
Priority date
Expiry dateNov 7, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel cytarabine derivatives of the formula ##STR1## where R.sup.1, R.sup.2 and R.sup.3, which can be identical or different, are each selected from the group consisting of hydrogen, aliphatic C.sub.2 -C.sub.5 -acyl, benzoyl or carboxy-C.sub.1 -C.sub.3 -alkylcarbonyl are described. The compounds are suitable for use directly or in the form of immunoliposomes for controlling diseases. Methods of preparing the novel cytarabine derivatives are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.